Elekta Ab Class B · OMXSTO:EKTA_B

Elekta Ab Class B — Investor Day (2016)

52 slides from Elekta Ab Class B's investor day presentation, 2016

  1. Slide 1: ASTRO 2016 Boston Elekta Capital Markets Presentation

    ASTRO 2016 Boston Elekta Capital Markets Presentation 1

  2. Slide 2: Important information

    Important information This presentation includes forward-looking statements including, but not limited to, statements relating to operational and financial performance, market conditions, and other similar matters. These forward-looking statements are based on current expectations about future event

  3. Slide 3: Elekta Capital Markets Presentation - Richard Hausmann, President and CEO

    Elekta Capital Markets Presentation Richard Hausmann President and CEO

  4. Slide 4: Some 30 years of experience in the medical device industry

    Some 30 years of experience in the medical device industry Siemens • Magnetic Resonance & Computed Tomography • President & CEO of Computed Tomography • President & CEO of Siemens China GE Healthcare • President and CEO of Global MR Business • Turned around USD 2.4 bn business with full P&L responsi

  5. Slide 5: My first months

    My first months Assumed position as CEO June 10 Gamma Knife Capital 100+ Visited ESTRO Society Markets Q1 customer Elekta 2016 Meeting report meetings offices around Day the world Turin Amsterdam AGM and BoD Stockholm FOCUS AREAS: • Strategic direction • Organization • Priorities • 5 | Focus where i

  6. Slide 6: Focus where it matters

    ASTRO 2016 Focus where it matters • 11,000 attendees • 1,700 poster presentations • 800 at the users meeting 6 | Focus where it matters

  7. Slide 7: Strategic direction going forward

    Strategic direction going forward

  8. Slide 8: Health care, oncology and radiation medicine trends

    HEALT H CARE MACR O TRENDS Value-based Consolidation health care Quality ONCOLOGY 20x of Life CARE TRENDS 2x Incidence Decision points available in next 10 years through 4x by 2040 explosion RADI AT I ON of data Growth in the use of Combination SRS and SBRT over MEDICINE the next 10 years TRENDS the

  9. Slide 9: Facilitate continuous improvement in efficiency, quality and outcomes

    1. How to manage the department in times of cost pressure while 2. How can we further optimize and personalize care so patients live longer with a high quality improving outcomes? of life? Facilitate continuous Achieving cancer control improvement in with no harm to healthy efficiency, quality tissu

  10. Slide 10: Oncology Informatics and Treatment Solutions

    RADIATION PARTICLE ONCOLOGY & MEDICAL ONCOLOGY THERAPY REGISTRY INFORMATICS EMR ‖ Treatment pathway centric SURGERY ‖ Vendor & therapy agnostic ‖ Localized to markets MOSAIQ® TREATMENT SOLUTIONS ‖ Devices & software ‖ Imaging centric ‖ Adaptive workflows Gamma Knife® Linac RT and MR-linac RT Radiosu

  11. Slide 11: The two businesses with different approaches

    The two businesses with different approaches TREATMENT SOLUTIONS ONCOLOGY INFORMATICS • Customer: RT/Physicist/Neurosurgeon • Customer: CEO, CIO, Administration • Capital/Product sale • High level of customization, workflow specific • Standard configurations • Integration of legacy SW, HIS SALES • M

  12. Slide 12: We are building on a strong MOSAIQ market position

    We are building on a strong MOSAIQ® market position US MARKET SHARE Elekta 51% 12 | Focus where it matters Oncology Information Systems, by Manufacturer, as of 2015/16 IMV Census Survey US Market only

  13. Slide 13: Value-based medicine requires a continuous improvement mindset based on big data

    Value-based medicine requires a continuous improvement mindset based on “big data” MOSAIQ ® ONCOLOGY ANALYTICS ACTIONABLE ANALYTICS MOSAIQ ® AUTOMATION TOOLS QUALITY CONTROL DECISION SUPPORT CONTINUOUS VALUE- BASED MOSAIQ ® WORKFLOW EFFICIENCY IMPROVEMENT MEDICINE COMPREHENSIVE WORKFLOW MANAGEMENT S

  14. Slide 14: World leading therapy solutions

    World leading therapy solutions CONVENTIONAL LGK AND BRACHYTHERAPY MR ADAPTIVE RT LINAC RT NEUROSURGERY 4D Dynamic Radiosurgery On-line adaptive Leksell Image-guided adaptive MRI-guided adaptive with Monaco® & Versa HD™ Gamma Knife® brachytherapy radiation therapy 14 | Focus where it matters

  15. Slide 15: Elekta's market position in treatment systems

    Elekta’s market position in treatment systems Linacs NEW ORDERS NEW SOCKETS* INSTALLED BASE Other Other 10% Other 14% 23% Elekta Elekta 39% Elekta 24% 51% Varian Varian Varian 51% 35% 53% Note: Order intake of linear accelerators in FY 2015/16 15 | Focus where it matters *New radiation therapy depar

  16. Slide 16: No harm to healthy tissue

    No harm to healthy tissue Ability to wrap dose around target (conformality) 2D 3D IMRT VMAT HD Dynamic Gamma Knife® Radiosurgery SRS & Interv RT

  17. Slide 17: Reduce uncertainties

    No harm to healthy tissue Reduce uncertainties (tighter margins) Locate target Image Guided RT based on pre-plan Ability to wrap dose around target (conformality) 2D 3D IMRT VMAT HD Dynamic Gamma Knife® Radiosurgery SRS & Interv RT

  18. Slide 18: Reduce uncertainties

    No harm to healthy tissue Adapt plan at the time of treatment Reduce uncertainties (tighter margins) Locate target Image Guided RT based on pre-plan Ability to wrap dose around target (conformality) 2D 3D IMRT VMAT HD Dynamic Gamma Knife® Radiosurgery SRS & Interv RT

  19. Slide 19: Reduce uncertainties

    No harm to healthy tissue Adapt plan at the time of MR-adaptive RT treatment Reduce uncertainties (tighter margins) Locate target Image Guided RT based on pre-plan Ability to wrap dose around target (conformality) 2D 3D IMRT VMAT HD Dynamic Gamma Knife® Radiosurgery SRS & Interv RT

  20. Slide 20: MRI adaptive RT: MR-linac

    MRI adaptive RT: MR-linac State-of-the-art Integrated Adaptive radiotherapy MR-imaging workflow system Launch in second half of Ambition: 75 calendar year orders until 2017 2019 20 | Focus where it matters

  21. Slide 21: Priorities going forward

    Priorities going forward 21

  22. Slide 22: Five priorities to accelerate our performance

    Five priorities to accelerate our performance Pursue excellence in all we do Profitable 1z Work as one company growth Strengthen customer experience and sales Cost Be recognized as the innovation leader Complete our cost turnaround program 22 | Focus where it matters 22

  23. Slide 23: Pursue excellence in all we do

    Pursue excellence in all we do PRODUCT LIFECYCLE • Customer-centric treatment solutions as well as MANAGEMENT patient-centric oncology informatics for better From Idea to Solution outcomes CUSTOMER RELATIONSHIP • Right messages and global sales focus to secure MANAGEMENT profitable growth From Aware

  24. Slide 24: Strengthen customer experience and sales

    Strengthen customer experience and sales • Strengthen global marketing capabilities • Excellence in sales processes • Drive aftermarket sales and support 24 | Focus where it matters

  25. Slide 25: Work as one company

    1z 39 | 25 | Focus where it matters

  26. Slide 26: Inspiring, Open, Energetic, Confident

    1z • Inspiring • Open • Energetic • Confident • 26 | Focus where it matters

  27. Slide 27: Our new values at Elekta

    1z Our new values at Elekta: WE WORK AS We work collaboratively and inclusively together. Only then can we truly focus on getting things ONE TEAM done for our customers and their patients. WE DO We act with accountability and integrity, WHAT taking personal and collective responsibility WE SAY to ma

  28. Slide 28: On track to reach the targets in the transformation program

    On track to reach the targets in the transformation program EBITA margin of in 2017/18 Cost reductions of Net working capital to sales below SEK *M with full effect 2017/18 in 2016/17 28 | Focus where it matters *Base year 2014/15, excluding currency effects

  29. Slide 29: Cost-saving activities

    Cost-saving activities OPERATING COST REDUCTIONS COGS REDUCTIONS Lean administration Cost analysis Shared service center Supplier economics analysis Prioritization of R&D projects Value chain analytics Consolidation of marketing Structured RFQ process Scale/geographic footprint 29 | Focus where it m

  30. Slide 30: On track to improve EBITA margin to 20%

    On On track to improve EBITA margin to 20% MARGIN DEVELOPMENT (illustrative) 47% 46% 43% 41% 41% Gross 40% margin 23% 22% 20% 16% EBITA 14% 15% margin 11/12 12/13 13/14 14/15 15/16 Q1 rolling 12 months 30 | Focus where it matters * Base year 2014/15, excluding currency effect and bad debt

  31. Slide 31: Be recognized as the innovation leader

    Be recognized as the innovation leader 31 | Focus where it matters

  32. Slide 32: Elekta Capital Markets Presentation - John Lapré, CTO

    Elekta Capital Markets Presentation John Lapré Chief Technology Officer

  33. Slide 33: Elekta has pioneered the development of radiation therapy

    Elekta has pioneered the development of radiation therapy First to integrate CBCT First Monte Carlo Introduction of First on-line Pioneered and introduce highest adaptive based Treatment Radiosurgery Image-guided performing radiosurgery Planning System with Gamma radiotherapy MLC in market system; I

  34. Slide 34: Oncology Informatics and Treatment Solutions

    RADIATION PARTICLE ONCOLOGY & MEDICAL ONCOLOGY THERAPY REGISTRY INFORMATICS EMR SURGERY MOSAIQ® TREATMENT SOLUTIONS Gamma Knife® Linac RT and MR-linac RT Radiosurgery & Brachytherapy SRS & SBRT Neurosurgery (Research*) SERVICES & SUPPORT *not available for sale – research only 34 | Focus where it ma

  35. Slide 35: Introducing HD Dynamic Radiosurgery

    Introducing HD Dynamic Radiosurgery (1,024 dynamic control points) modulation per arc stereotactic treatments in fewer, single or partial arcs Deliver and within standard treatment slots, irrespective of complexity or anatomy 35 | Focus where it matters

  36. Slide 36: Online adaptive Leksell Gamma Knife

    Online adaptive Leksell Gamma Knife® Online dose Frameless SRS Ultrafast adaptation with similar planning and precision optimization 36 | Focus where it matters

  37. Slide 37: Image guided adaptive brachytherapy

    Image guided adaptive brachytherapy Targeted, minimally invasive RT Improved outcomes in bulky (>5cm) cervical cancer at 3 years with IGABT Largest CT/MR compatible applicator portfolio Period 1998 – 2000 Period 2001 - 2008 (Learning period) 92% 70% 64% 65% Automation tools such as applicator modeli

  38. Slide 38: Monaco 5.11

    • • • • • • • • • • •• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •

  39. Slide 39: Innovation focus moving forward

    Innovation focus moving forward 39

  40. Slide 40: Imaging in radiation therapy is a key element

    Imaging in radiation therapy is a key element Focus where it matters Specificity Deliver dose where it matters SAFETY Be quick but Treatment as Speed Simplicity not in a hurry simple as needed 40 | Focus where it matters

  41. Slide 41: Wrapping high dose as tight as possible is sufficient in static situations

    Wrapping high dose as tight as possible to a target is sufficient in static situations… 41 | Focus where it matters

  42. Slide 42: Targets often move and only advanced imaging helps reduce margins

    …but targets often move and only advanced imaging helps reduce margins and further limit dose to healthy tissue… 42 | Focus where it matters

  43. Slide 43: Seamless and online plan adaptation is vital

    …and for day-to-day changes of shape and position, seamless and online plan adaptation is vital. ONLINE ADAPTIVE • Diagnostic Imaging • Dose Calculation • Dose Adjustment • Repositioning • Plan Adaptation 43 | Focus where it matters

  44. Slide 44: A new paradigm

    A new paradigm Conventional IGRT workflow Locating Treat Imaging & Locating target Treat Planning Locating target Treat Simulation Locating target Treat target Plan = dose objectives Adjust patient position to the plan Adaptive workflow Adapt plan & deliver Imaging & Initial Adapt plan & deliver Sim

  45. Slide 45: A new space: MR-Adaptive RT

    A new space: MR-Adaptive RT LIVE Clinical Diagnostic High-Field MR Decisions Image Quality Informed Advanced Response Radiation Adaptive Therapy Session HD Dynamic Architecture Radiosurgery 45 | Focus where it matters

  46. Slide 46: Crystal Clear Confidence

    Crystal Clear Confidence Elekta’s MR-linac brings together the capability of high field diagnostic MR imaging, the highest standard of precision radiation therapy delivery & sophisticated adaptive workflow software for the first time.

  47. Slide 47: MR Adaptive RT

    MR Adaptive RT: Soft tissue imaging with diagnostic quality combined with HD Dynamic Radiosurgery capabilities MR-Linac Diagnostic MRI  True Monte Carlo planning with non gridded optimisation +  High number of control points  FFF delivery  Fast leaf speed  Low leaf transmission 47 | Focus where

  48. Slide 48: Adaptive session architecture

    MR-linac will be equipped with world first ‘Adaptive session architecture’ 48 | Focus where it matters

  49. Slide 49: Elekta

    CElekta

  50. Slide 50: Elekta Capital Markets Presentation - Chris Schultz

    Elekta Capital Markets Presentation Chris Schultz

  51. Slide 51: Image guided & Adaptive Radiation Therapy at the Medical College of Wisconsin

    Image guided & Adaptive Radiation Therapy at the Medical College of Wisconsin Christopher Schultz, MD, FACR, FASTRO Professor and Chairman Department of Radiation Oncology Medical College of Wisconsin

  52. Slide 52: Elekta

    CElekta

Elekta — Investor Day (2016) on 6ix